1-3
2026
影响因子区间
—
平台估算
24%
2025
中国作者发文占比
—
收费
期刊简介:Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.
【译文】在实验和临床水平上解决广泛的药理学和肿瘤学问题,癌症化疗与药理学是一本杰出的期刊。在这个快速出版媒介中,主要关注新的抗癌药物,它们的实验筛选、临床前毒理学和药理学、单药和联合用药方式,以及临床I、II和III期试验。对于提供以下领域结果的药理学家和肿瘤学家来说是必读之物:临床毒理学、药代动力学、药效学、药物相互作用以及癌症治疗策略中的化疗适应症。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |